Streetbeat News

Earnings

TRVI

Trevi Therapeutics reported Q3 2023 GAAP EPS of $(0.08), beating the analyst consensus estimate of $(0.09) by 11.11%. This represents a 33.33% increase over losses from the same period last year.

Portfolio Pulse from saritha@benzinga.com

November 09, 2023 | 9:56 pm

BGNE

BeiGene (NASDAQ:BGNE) reported Q3 earnings of $2.01 per share, beating the analyst consensus estimate of $(3.09) by 165.05%. This is a 137.29% increase over losses of $(5.39) per share from the same period last year. The company also reported quarterly sales of $781.31 million, beating the analyst consensus estimate of $632.77 million by 23.47%. This is a 101.56% increase over sales of $387.63 million the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:55 pm

CURI

CuriosityStream (NASDAQ:CURI) reported Q3 earnings, beating estimated earnings by 6.67% with an EPS of $-0.14. However, revenue was down $7.94 million from the same period last year. Last quarter, the company missed on EPS by $0.03, which led to a 7.32% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:55 pm

FORA

Forian (NASDAQ:FORA) reported Q3 earnings, beating estimated earnings by 633.33% with an EPS of $0.16, compared to an estimate of $-0.03. However, revenue was down $1.83 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 1.54% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:55 pm

BLFS

BioLife Solns (NASDAQ:BLFS) reported Q3 earnings, beating estimated earnings by 13.16% with an EPS of $-0.33 versus an estimate of $-0.38. However, revenue was down $7.42 million from the same period last year. Last quarter, the company missed on EPS by $0.04, which was followed by a 28.71% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 09, 2023 | 9:55 pm

OSA

ProSomnus (NASDAQ:OSA) reported Q3 2023 earnings with losses of $(0.70) per share, missing the analyst consensus estimate of $(0.34) by 105.88%. This is a 400% decrease from the same period last year. However, the company's quarterly sales of $7.07M beat the estimate of $7.03M by 0.58%, marking a 41.48% increase from last year.

Portfolio Pulse from totan@benzinga.com

November 09, 2023 | 9:54 pm

KOPN

Kopin Corporation reported Q3 earnings per share (EPS) of $(0.02), beating the analyst consensus estimate of $(0.03) by 33.33%. This is a 60% increase over losses from the same period last year. The company also reported quarterly sales of $10.60 million, beating the analyst consensus estimate of $10.03 million by 5.68%, but this is a 20.77% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:54 pm

CLFD

Clearfield Inc. has projected its Q1 net sales to be between $28M and $32M, which is significantly lower than the estimated $48.13M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:54 pm

DOCS

Doximity (NYSE:DOCS) reported Q2 earnings of $0.22 per share, beating the analyst consensus estimate of $0.18 by 22.22%. This is a 29.41% increase from the same period last year. The company also reported quarterly sales of $113.61 million, beating the analyst consensus estimate of $109.06 million by 4.17%. This is an 11.18% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:54 pm

CLFD

Clearfield reported Q4 earnings per share (EPS) of $0.17 and net sales of $49.7M, slightly above the estimated $48.76M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 9:53 pm